AI assistant
Sending…
Invivyd, Inc. — Director's Dealing 2021
Aug 6, 2021
33564_dirs_2021-08-05_05b834ac-124b-4e8e-abfc-9cdd400d0cf5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Adagio Therapeutics, Inc. (ADGI)
CIK: 0001832038
Period of Report: 2021-08-05
Reporting Person: Russo Rene (Director)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 1985295 | Direct |
More from Invivyd, Inc.
Declaration of Voting Results & Voting Rights Announcements
2026
May 19
Share Issue/Capital Change
2026
May 14
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 14
Investor Presentation
2026
Apr 9
Annual Report
2026
Apr 6
Proxy Solicitation & Information Statement
2026
Apr 6
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19